Neovasc Inc. EBT

EBT of NVCN for past 10 years: annual, quarterly and twelve month trailing (TTM) including EBT growth rates and interactive chart. Earnings before tax (EBT) measures a company's financial performance. Its calculation is revenue minus expenses, excluding taxes. EBT is a line item on a company's income statement. It shows company earnings with the cost of goods sold (COGS), interest, depreciation, general and administrative expenses, and other operating expenses deducted from gross sales.


Highlights and Quick Summary

  • EBT for the quarter ending March 31, 2022 was $-10.2 Million (a 69.17% increase compared to previous quarter)
  • Year-over-year quarterly EBT increased by 13.39%
  • Annual EBT for 2021 was $-24.5 Million (a -20.66% decrease from previous year)
  • Annual EBT for 2020 was $-30.9 Million (a -13.87% decrease from previous year)
  • Annual EBT for 2019 was $-35.8 Million (a -65.15% decrease from previous year)
  • Twelve month EBT ending March 31, 2022 was $-32.6 Million (a 32.41% increase compared to previous quarter)
  • Twelve month trailing EBT increased by 23.23% year-over-year
Trailing EBT for the last four month:
31 Mar '22 31 Dec '21 30 Sep '21 30 Jun '21
$-32.6 Million $-24.6 Million $-23.7 Million $-26.5 Million
Visit stockrow.com/NVCN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EBT of Neovasc Inc.

Most recent EBTof NVCN including historical data for past 10 years.

Interactive Chart of EBT of Neovasc Inc.

Neovasc Inc. EBT for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $-10.16
2021 $-6.01 $-7.48 $-8.96 $-2.18 $-24.48
2020 $-5.08 $-10.23 $-9.93 $-4.1 $-30.86
2019 $-12.31 $-6.22 $-7.92 $-8.65 $-35.83
2018 $11.61 $-14.58 $-49.08 $-55.83 $-102.81
2017 $-5.0 $-4.35 $-5.28 $-7.79 $-23.29
2016 $37.23 $-29.05 $-83.64 $-10.83 $-86.29
2015 $-7.21 $-7.64 $-6.75 $-4.96 $-26.56
2014 $-6.69 $-4.21 $-5.93 $-0.34 $-17.18
2013 $-2.12 $-1.38 $-1.21 $-1.84 $-6.55
2012 $3.62 $-1.21 $-1.5 $-1.26 $-0.35
2011 $1.8 $-3.86

Business Profile of Neovasc Inc.

Sector: Healthcare
Industry: Medical Devices
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.